These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1213656)

  • 21. Biochemical effects of calcium supplementation in postmenopausal osteoporosis.
    Horowitz M; Need AG; Morris HA; Wishart J; Nordin BE
    Eur J Clin Nutr; 1988 Sep; 42(9):775-8. PubMed ID: 3181110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.
    DiMeglio LA; Ford L; McClintock C; Peacock M
    Bone; 2004 Nov; 35(5):1038-45. PubMed ID: 15542028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
    Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skeletal response to recombinant human growth hormone (rhGH) in children treated with long-term corticosteroids.
    Sanchez CP; Goodman WG; Brandli D; Goldenhersh M; Murray C; Carlton E; Hahn T; Salusky IB
    J Bone Miner Res; 1995 Jan; 10(1):2-6. PubMed ID: 7747627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone injections improve bone quality in a mouse model of osteogenesis imperfecta.
    King D; Jarjoura D; McEwen HA; Askew MJ
    J Bone Miner Res; 2005 Jun; 20(6):987-93. PubMed ID: 15883639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Juvenile osteoporosis: bone findings in seven patients.
    Jowsey J; Johnson KA
    J Pediatr; 1972 Sep; 81(3):511-7. PubMed ID: 5049819
    [No Abstract]   [Full Text] [Related]  

  • 27. [Methimazole versus methimazole and diphosphonates in hyperthyroid and osteoporotic patients].
    Lupoli GA; Fittipaldi MR; Fonderico F; Panico A; Colarusso S; Di Micco L; Cavallo A; Costa L; Paglione A; Lupoli G
    Minerva Endocrinol; 2005 Jun; 30(2):89-94. PubMed ID: 15988404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biochemical markers of bone remodelling and their usefulness in the diagnosis of osteoporosis].
    Marcinowska-Suchowierska E; Lisawa A; Marowska J; Lorencewicz Z; Tałałaj M; Brzozowski R; Lorenc R
    Wiad Lek; 1992 Sep; 45(17-18):647-54. PubMed ID: 1295248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Urinary hydroxyproline excretion in generalized bone diseases].
    Czitober H; Raab W
    Wien Z Inn Med; 1967; 48(10):401-8. PubMed ID: 5620579
    [No Abstract]   [Full Text] [Related]  

  • 31. [Histomorphometric and biological data on osteoporosis due to immobilization].
    Minaire P; Meunier P; Edouard C; Bernard J; Courpron P
    Rev Rhum Mal Osteoartic; 1975; 42(7-9):479-88. PubMed ID: 1179130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primary hyperparthyroidism. Analysis of 152 patients with special reference to acute life threatening complications (acute hyperparathyroidism)].
    Kistler H
    Schweiz Med Wochenschr Suppl; 1976; (3):1-61. PubMed ID: 208139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteoporosis in ovarian dysgenesis.
    Brown DM; Jowsey J; Bradford DS
    J Pediatr; 1974 Jun; 84(6):816-20. PubMed ID: 4826614
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of fluoride therapy on nondialyzable urinary hydroxyproline, serum alkaline phosphatase, parathyroid hormone, and 25-hydroxyvitamin D.
    Manzke E; Rawley R; Vose G; Roginsky M; Rader JI; Baylink DJ
    Metabolism; 1977 Sep; 26(9):1005-10. PubMed ID: 895531
    [No Abstract]   [Full Text] [Related]  

  • 35. Calcium metabolism and 47calcium kinetics before and after long-term thyrocalcitonin treatment in senile osteoporosis.
    Caniggia A; Gennari C; Bencini M; Cesari L; Borrello G
    Clin Sci; 1970 Apr; 38(4):397-407. PubMed ID: 5428804
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of growth hormone in osteoporosis.
    Aloia JF; Zanzi I; Ellis K; Jowsey J; Roginsky M; Wallach S; Cohn SH
    J Clin Endocrinol Metab; 1976 Nov; 43(5):992-9. PubMed ID: 993324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ageing of bone: its relation to osteoporosis and osteoarthrosis in post-menopausal women.
    Dequeker J; Burssens A; Creytens G; Bouillon R
    Front Horm Res; 1975; 3():116-30. PubMed ID: 791695
    [No Abstract]   [Full Text] [Related]  

  • 38. Attempts to prevent disuse osteoporosis by treatment with calcitonin, longitudinal compression and supplementary calcium and phosphate.
    Hantman DA; Vogel JM; Donaldson CL; Friedman R; Goldsmith RS; Hulley SB
    J Clin Endocrinol Metab; 1973 May; 36(5):845-58. PubMed ID: 4698244
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of osteoporosis of ageing with 1alpha-hydroxycholecalciferol.
    Lund B; Hjorth L; Kjaer I; Reimann I; Friis T; Andersen RB; Sorensen OH
    Lancet; 1975 Dec; 2(7946):1168-71. PubMed ID: 53656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biological exploration of osteoporosis (author's transl)].
    Hioco D
    J Belge Rhumatol Med Phys; 1973 Sep; 28(5):287-92. PubMed ID: 4794041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.